Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Prolong Pharmaceuticals)"
Count: 15
Selected: 0
| NCT ID | Title |
|---|
| NCT04677777 | Safety Study of PP-007 in Subjects With Acute Ischemic Stroke | ||
| NCT03559387 | Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia | ||
| NCT02950857 | A Study of EPEG in Beta Thalassemia Patients | ||
| NCT02754999 | A Phase 1 Safety Study of SANGUINATE™ In Patients With Acute Severe Anemia. | ||
| NCT02672540 | A Study of SANGUINATE for the Treatment of Vaso-occlusive Crisis (VOC) in Adult Sickle Cell Disease Patients | ||
| NCT02658162 | A Study on SANGUINATE™ for the Reduction of Delayed Graft Function in Kidney Transplant Patients | ||
| NCT02600390 | SANGUINATE™ in Sickle Cell Disease Associated Leg Ulcer | ||
| NCT02533362 | ANF-Rho in the Treatment of Chronic Neutropenia | ||
| NCT02490202 | Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant | ||
| NCT02437422 | Study to Assess the Safety and Impact on Humoral Sensitization of SANGUINATE in Patients With End Stage Renal Disease | ||
| NCT02411708 | Study of SANGUINATE™ In the Treatment of Sickle Cell Disease Patients With Vaso-Occlusive Crisis | ||
| NCT02323685 | Safety and Effect of SANGUINATE™ Infusion in Patients at Risk of Delayed Cerebral Ischemia (DCI) Following Subarachnoid Hemorrhage (SAH) | ||
| NCT01848925 | Study of SANGUINATE™ Versus Hydroxyurea in Sickle Cell Disease (SCD) Patients | ||
| NCT01847222 | An Assessment of the Safety and Pharmacokinetics of Ascending Doses of SANGUINATE™ in Healthy Volunteers. | ||
| NCT01374165 | Safety and Pharmacokinetics of SANGUINATE™ in Sickle Cell Disease (SCD) Patients |
